Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation

Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation

Background. Rabbit antithymocyte globulin (rATG) is the most widely used kidney transplant induction immunotherapy in the United States. It was recently Food and Drug Administration approved for this indication with typical dose recommendations of 1.5 mg/kg for up to 7 days given via a central line....

Full description

Bibliographic Details
Main Authors:	Namita Singh, MD, Ana P. Rossi, MD, Marizela Savic, PharmD, Ronald J. Rubocki, PhD, Mark G. Parker, MD, John P. Vella, MD
Format:	Article
Language:	English
Published:	Wolters Kluwer 2018-02-01
Series:	Transplantation Direct
Online Access:	http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000765

Similar Items

Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C
by: R. F. Saidi, et al.
Published: (2011-10-01)

Successful Desensitization of a Patient with Aplastic Anemia to Antithymocyte Globulin
by: Stephanie A. Wolanin M.D., et al.
Published: (2015-03-01)

Reassessing Rabbit Antithymocyte Globulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry
by: Isa F. Ashoor, MD, et al.
Published: (2020-09-01)

Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation
by: Hoa Le Mai, PhD, et al.
Published: (2018-04-01)

Effectiveness and Safety of Rabbit Antithymocyte Globulin for Renal Transplant Patients with Rejection in Taiwan
by: Yuan-Chen Li, et al.
Published: (2010)

Polyclonal rabbit antithymocyte globulin (thymoglobulin): immunomodulatory effects and new aspects of its clinical application
by: A D Kulagin, et al.
Published: (2010-07-01)

Antithymocyte Globulin Antibody Titer Congruent With Kidney Transplantation: Analysis of Incidence, Outcomes, Cost, and Alternative Targets
by: Sherene Lattimore, BS, et al.
Published: (2019-10-01)

The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation.
by: Kamilla Linhares, et al.
Published: (2021-01-01)

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A,
by: Marlene Pereira Garanito, et al.
Published: (2014-09-01)

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A
by: Marlene Pereira Garanito, et al.
Published: (2014-09-01)

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A
by: Marlene Pereira Garanito, et al.
Published: (2014-09-01)

The Benefit of Sirolimus Maintenance Immunosuppression and Rabbit Antithymocyte Globulin Induction in Liver Transplant Recipients That Develop Acute Kidney Injury in the Early Postoperative Period
by: Benjamin T. Duhart, et al.
Published: (2015-01-01)

Graves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child
by: In Su Choi, et al.
Published: (2015-07-01)

Colonic EBV-Associated Lymphoproliferative Disorder in a Patient Treated with Rabbit Antithymocyte Globulin for Aplastic Anemia
by: Hiroko Sugimoto-Sekiguchi, et al.
Published: (2012-01-01)

Severe Acute Interstitial Nephritis: Response to Therapy With Antithymocyte Globulin
by: Tiffany Shao, et al.
Published: (2017-03-01)

Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient
by: Shamim Rafat, et al.
Published: (2017-01-01)

Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity.
by: Diana Stauch, et al.
Published: (2009-01-01)

A Comparison of Two Types of Rabbit Antithymocyte Globulin Induction Therapy in Immunological High-Risk Kidney Recipients: A Prospective Randomized Control Study.
by: F Burkhalter, et al.
Published: (2016-01-01)

Antithymocyte Globulin Induces a Tolerogenic Phenotype in Human Dendritic Cells
by: Tobias Roider, et al.
Published: (2016-12-01)

Acute Lung Injury during Antithymocyte Globulin Therapy for Aplastic Anemia
by: Ewan Christopher Goligher, et al.
Published: (2009-01-01)

Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
by: Ren Lin, et al.
Published: (2019-08-01)

Outcomes of optimized over standard protocol of rabbit antithymocyte globulin for severe aplastic anemia: a single-center experience.
by: Xingxin Li, et al.
Published: (2013-01-01)

Fatal Epstein-Barr Virus Reactivation in an Acquired Aplastic Anemia Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine A
by: Tohru Takahashi, et al.
Published: (2015-01-01)

APPLICATION OF ANTITHYMOCYTE GLOBULIN IN CHILDREN AFTER CADAVER KIDNEY TRANSPLANTATION. RETROSPECTIVE ANALYSIS
by: V.A. Goryainov, et al.
Published: (2011-01-01)

APPLICATION OF ANTITHYMOCYTE GLOBULIN IN CHILDREN AFTER CADAVER KIDNEY TRANSPLANTATION. RETROSPECTIVE ANALYSIS
by: V.A. Goryainov, et al.
Published: (2011-01-01)

Does Rabbit Antithymocyte Globulin (Thymoglobuline®) Have a Role in Avoiding Delayed Graft Function in the Modern Era of Kidney Transplantation?
by: Lluís Guirado
Published: (2018-01-01)

Role of antithymocyte globulin in reducing the incidence of complications after allogeneic hemopoietic cell transplantation
by: Yu R Zalyalov, et al.
Published: (2010-08-01)

Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications
by: G. R. Pourmand, et al.
Published: (2012-04-01)

Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium
by: Isa F. Ashoor, et al.
Published: (2021-04-01)

Low-dose rabbit anti-thymoglobin globulin versus basiliximab for induction therapy in kidney transplantation
by: Himanshu V Patel, et al.
Published: (2014-01-01)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
by: Rachel Jeong, et al.
Published: (2020-10-01)

Giant Cell Myocarditis with Incessant Ventricular Arrhythmias Treated Successfully with Methylprednisolone and Rat Antithymocyte Globulin
by: Mudassar Baig, et al.
Published: (2011-01-01)

Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin
by: de-Medeiros C.R., et al.
Published: (2000-01-01)

Acquired severe aplastic anemia treated with antithymocyte globulin and cyclosporine: An experience of regional cancer center, Western India
by: Ankit B Patel, et al.
Published: (2015-01-01)

A retrospective comparison of cyclophosphamide plus antithymocyte globulin with cyclophosphamide plus busulfan as the conditioning regimen for severe aplastic anemia
by: L.V.M. Ommati, et al.
Published: (2009-03-01)

Less graft-versus-host disease after rabbit antithymocyte globulin conditioning in unrelated bone marrow transplantation for leukemia and myelodysplasia: comparison with matched related bone marrow transplantation.
by: Elias Hallack Atta, et al.
Published: (2014-01-01)

Rabbit anti-thymocyte globulin induction in renal transplantation: review of the literature
by: Andress L, et al.
Published: (2014-01-01)

Critical Analysis of Apixaban Dose Adjustment Criteria
by: Anh Vu PharmD, et al.
Published: (2021-06-01)

Improved Protective Effect of Umbilical Cord Stem Cell Transplantation on Cisplatin-Induced Kidney Injury in Mice Pretreated with Antithymocyte Globulin
by: Željka Večerić-Haler, et al.
Published: (2016-01-01)

Burden of cytomegalovirus reactivation post kidney transplant with antithymocyte globulin use in Thailand: A retrospective cohort study [version 1; referees: 2 approved]
by: Maria N. Chitasombat, et al.
Published: (2018-09-01)